- Report
- April 2024
- 402 Pages
Global
From €4624EUR$4,950USD£3,912GBP
- Report
- August 2024
- 200 Pages
Global
From €2139EUR$2,290USD£1,810GBP
- Report
- February 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,549GBP
- Report
- February 2024
- 202 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- October 2022
- 194 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- November 2020
- 217 Pages
Global
From €3737EUR$4,000USD£3,161GBP
- Report
- January 2024
- 213 Pages
Global
From €4344EUR$4,650USD£3,675GBP
- Report
- April 2020
- 108 Pages
Global
From €1121EUR$1,200USD£948GBP
- Report
- August 2023
- 370 Pages
Global
From €2326EUR$2,490USD£1,968GBP
- Report
- January 2022
- 150 Pages
Global
From €2803EUR$3,000USD£2,371GBP
- Report
- July 2023
- 210 Pages
Global
From €1859EUR$1,990USD£1,573GBP
- Report
- August 2023
- 145 Pages
Global
From €2943EUR$3,150USD£2,490GBP
- Report
- July 2024
- 326 Pages
China
From €3737EUR$4,000USD£3,161GBP
- Report
- July 2024
- 187 Pages
China
From €1682EUR$1,800USD£1,423GBP
- Report
- September 2023
- 89 Pages
From €2756EUR$2,950USD£2,331GBP
- Report
- September 2023
- 87 Pages
Middle East, Africa
From €2756EUR$2,950USD£2,331GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3223EUR$3,450USD£2,727GBP
- Report
- September 2023
- 112 Pages
Europe
From €3223EUR$3,450USD£2,727GBP
- Report
- October 2024
- 104 Pages
Global
From €3500EUR$4,013USD£3,065GBP
- Report
- March 2024
- 132 Pages
Global
From €888EUR$950USD£751GBP

The MMR Vaccine is a vaccine used to protect against measles, mumps, and rubella. It is typically administered in two doses, with the first dose given to children between 12 and 15 months of age, and the second dose given between 4 and 6 years of age. The MMR Vaccine is a live attenuated vaccine, meaning that it contains weakened versions of the viruses it is designed to protect against.
The MMR Vaccine market is a subset of the larger Vaccines market, which is estimated to be worth billions of dollars. The MMR Vaccine market is driven by the need to protect against the three diseases it is designed to prevent, as well as the increasing demand for vaccines in general. The market is expected to grow in the coming years, as more countries adopt vaccination programs and the demand for vaccines increases.
Some of the major companies in the MMR Vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and AstraZeneca. Show Less Read more